1-([1,1'-Biphenyl]-4-yl(phenyl)methyl)-1H-imidazole

Catalog No. :
ACRCJG792
CAS No. :
60628-96-8
Molecular Formula :
C22H18N2
Molecular Weight :
310.40

IUPAC Name:1-([1,1'-biphenyl]-4-yl(phenyl)methyl)-1H-imidazole

1-([1,1'-Biphenyl]-4-yl(phenyl)methyl)-1H-imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%$57.00Login to see priceIn stockInquiry
500g97%$196.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-([1,1'-Biphenyl]-4-yl(phenyl)methyl)-1H-imidazole
IUPAC Name1-([1,1'-biphenyl]-4-yl(phenyl)methyl)-1H-imidazole
MDL No.MFCD00865567
Molecular FormulaC22H18N2
Molecular Weight310.40
SMILESN1(C(C2=CC=C(C3=CC=CC=C3)C=C2)C4=CC=CC=C4)C=CN=C1
InChI KeyOCAPBUJLXMYKEJ-UHFFFAOYSA-N
SynonymBifonazol | Bifonazolum | DL-338 | 1-[phenyl-(4-phenylphenyl)methyl]imidazole | MRF-0000274 | NCGC00018254-05 | NCGC00089815-04 | Bay H-4502 | HMS2093B09 | HMS2232J24 | Mycospor (TN) | 1-[biphenyl-4-yl(phenyl)methyl]imidazole | EINECS 262-336-6 | NSC75895
CAS No.60628-96-8
PubChem CID2378

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACRCJG792 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACRCJG792 route product structure diagram
    ACRCJG79260628-96-8 In Stock
Inquiry

2. ACRCJG792 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACRCJG792 route product structure diagram
    ACRCJG79260628-96-8 In Stock
Inquiry

Comments (0)